GENOCEA BIOSCIENCES INC (GNCA) Stock Analyst Earnings Estimates
NASDAQ:GNCA - Nasdaq - US3724274010 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.36M | 1.64M 20.59% | 578.003K -64.76% | -100.00% | |||||
| EBITDA YoY % growth | -37.89M 1.41% | -45.85M -21.01% | -50.53M -10.21% | -57.936M -14.66% | -62.526M -7.92% | -52.871M 15.44% | -45.601M 13.75% | N/A | |
| EBIT YoY % growth | -38.99M 1.34% | -46.99M -20.52% | -52.09M -10.85% | -42.84M 17.76% | -67.218M -56.90% | -56.985M 15.22% | -44.224M 22.39% | -35.008M 20.84% | |
| Operating Margin | N/A | -3,455.15% | -3,176.22% | -7,411.72% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -2.24 20.00% | -1.16 48.21% | -0.47 59.48% | -0.74 -58.43% | -0.85 -13.70% | -0.56 33.73% | -0.61 -7.86% | -0.67 -10.02% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -206.00% | -0.18 -267.20% | -0.19 -2.00% | -0.19 11.91% | -0.19 -5.56% | -0.20 -11.11% | -0.20 -5.26% |
| Revenue Q2Q % growth | -100.00% | -100.00% | |||||
| EBITDA Q2Q % growth | -13.974M -1.26% | -14.586M -37.99% | -15.504M -30.84% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.67M 40.41% | -12.954M -10.53% | -12.954M 3.40% | -13.464M 14.62% | -13.464M -55.29% | -14.28M -10.24% | -14.28M -10.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -0.22 -29.41% | -0.19 | -0.03 | -18.51% |
| Q4 2021 Q2Q % growth | -0.19 17.39% | -0.20 | 0.01 | 6.86% |
| Q3 2021 Q2Q % growth | -0.05 37.50% | -0.20 | 0.15 | 75.18% |
| Q2 2021 Q2Q % growth | -0.06 84.62% | -0.19 | 0.13 | 67.68% |
| Q1 2021 Q2Q % growth | -0.17 63.04% | -0.20 | 0.03 | 15.82% |
| Q4 2020 Q2Q % growth | -0.23 32.35% | -0.21 | -0.02 | -8.41% |
| Q3 2020 Q2Q % growth | -0.08 71.43% | -0.25 | 0.17 | 67.59% |
| Q2 2020 Q2Q % growth | -0.39 7.14% | -0.41 | 0.02 | 5.59% |
| Q1 2020 Q2Q % growth | -0.46 61.67% | -0.36 | -0.10 | -28.12% |
| Q4 2019 Q2Q % growth | -0.34 | -0.40 | 0.06 | 14.53% |
| Q3 2019 Q2Q % growth | -0.28 | -0.47 | 0.19 | 40.00% |
| Q2 2019 Q2Q % growth | -0.42 | -0.67 | 0.25 | 37.37% |
| Q1 2019 Q2Q % growth | -1.20 | -0.71 | -0.49 | -69.68% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 270K | 433.5K | -163.5K | -37.72% |
| Q3 2021 Q2Q % growth | 1.64M 264.44% | 1.64M | % | |
| Q2 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |